Labcorp Holdings (FRA:N6B) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:N6B Labcorp Holdings Inc FRA:N6B
80 GF Score
Price €266.00
GF Value €234.36
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Labcorp Holdings Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:N6B
80GF Score
Labcorp Holdings Inc FRA:N6B
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Labcorp Holdings (FRA:N6B) Overvalued in 2026?

Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued. The current stock price of €266.00 is trading 13.5% above its estimated GF Value™ of €234.36. GuruFocus considers Labcorp Holdings to be Modestly Overvalued.

Key valuation signals for FRA:N6B:

  • Dividends Received:
  • GF Value™: €234.36 vs. price of €266.00 (13.5% above fair value)
  • GF Score™: 80/100 with 8 warning signs

No single metric tells the full story. See the FRA:N6B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Labcorp Holdings Business Description

Other Exchanges LH:USA0JSY:UKN6B:Germany
Address 358 South Main Street, Burlington, NC, USA, 27215
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
80GF Score

Get the complete analysis for FRA:N6B

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€266.00
Price
€234.36
GF Value